FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893022109> ?p ?o ?g. }

• W2893022109 endingPage "e000220" @default.
• W2893022109 startingPage "e000220" @default.
• W2893022109 abstract "Septic shock is a public health problem with high mortality. There remains a knowledge gap regarding the optimal resuscitation fluid to improve clinical outcomes, and the underlying mechanism by which fluids exert their effect. Shock-induced endotheliopathy (SHINE) is thought to be a shared pathophysiologic mechanism associated with worsened outcomes in critically ill trauma and sepsis patients. SHINE is characterized by breakdown of the glycocalyx-a network of membrane-bound proteoglycans and glycoproteins that covers the endothelium. This has been associated with capillary leakage and microvascular thrombosis, organ dysfunction, and mortality. Biomarkers of SHINE have been shown to correlate with clinical outcomes in patients with septic shock. Interventions to mitigate SHINE may improve outcomes in patients with septic shock. In surgical/trauma patients with septic shock, initial plasma resuscitation as compared with balanced crystalloid (BC) resuscitation will mitigate biomarkers of SHINE and improve clinical outcomes.A pilot, single-center randomized controlled trial (RCT) will compare initial plasma to BC resuscitation in surgical and trauma patients with septic shock. Patients will be enrolled based on a Sepsis Screening Score of ≥4 with a suspected source of infection. Patient randomization only occurs if they meet the criteria: (1) hypotension with mean arterial pressure <65 mm Hg, and (2) evidence of hypoperfusion including lactic acid >4 mmol/L, altered mental status or decreased urine output of <0.5 mL/kg in the past hour.The primary outcome is a reduction in serum biomarkers at 6 hours. Secondary outcomes will include clinical outcomes such as intensive care unit-free days, organ dysfunction, and in-hospital mortality.This trial will provide insights into the effects of initial plasma resuscitation on SHINE. Furthermore, it will provide unbiased estimates regarding the feasibility, safety, and clinical efficacy of plasma resuscitation in septic shock on which to base subsequent adequately powered multicenter RCTs.ClinicalTrials.gov (NCT03366220)." @default.
• W2893022109 created "2018-10-05" @default.
• W2893022109 creator A5006698235 @default.
• W2893022109 creator A5022085835 @default.
• W2893022109 creator A5026192603 @default.
• W2893022109 creator A5042251160 @default.
• W2893022109 creator A5055279687 @default.
• W2893022109 creator A5056060130 @default.
• W2893022109 creator A5072490624 @default.
• W2893022109 date "2018-09-01" @default.
• W2893022109 modified "2023-10-16" @default.
• W2893022109 title "Protocol for a pilot randomized controlled trial comparing plasma with balanced crystalloid resuscitation in surgical and trauma patients with septic shock" @default.
• W2893022109 cites W1967433109 @default.
• W2893022109 cites W2003890435 @default.
• W2893022109 cites W2004195549 @default.
• W2893022109 cites W2018680532 @default.
• W2893022109 cites W2085452577 @default.
• W2893022109 cites W2108696783 @default.
• W2893022109 cites W2116998724 @default.
• W2893022109 cites W2123095004 @default.
• W2893022109 cites W2137015167 @default.
• W2893022109 cites W2144589352 @default.
• W2893022109 cites W2145415920 @default.
• W2893022109 cites W2255691977 @default.
• W2893022109 cites W2281271151 @default.
• W2893022109 cites W2317609637 @default.
• W2893022109 cites W2340080951 @default.
• W2893022109 cites W2501243641 @default.
• W2893022109 cites W2575911653 @default.
• W2893022109 cites W2586773298 @default.
• W2893022109 cites W2592381620 @default.
• W2893022109 cites W2620241325 @default.
• W2893022109 cites W2621635141 @default.
• W2893022109 cites W2811140693 @default.
• W2893022109 cites W3016555942 @default.
• W2893022109 cites W4236805817 @default.
• W2893022109 doi "https://doi.org/10.1136/tsaco-2018-000220" @default.
• W2893022109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6157534" @default.
• W2893022109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30271882" @default.
• W2893022109 hasPublicationYear "2018" @default.
• W2893022109 type Work @default.
• W2893022109 sameAs 2893022109 @default.
• W2893022109 citedByCount "5" @default.
• W2893022109 countsByYear W28930221092020 @default.
• W2893022109 countsByYear W28930221092021 @default.
• W2893022109 countsByYear W28930221092022 @default.
• W2893022109 countsByYear W28930221092023 @default.
• W2893022109 crossrefType "journal-article" @default.
• W2893022109 hasAuthorship W2893022109A5006698235 @default.
• W2893022109 hasAuthorship W2893022109A5022085835 @default.
• W2893022109 hasAuthorship W2893022109A5026192603 @default.
• W2893022109 hasAuthorship W2893022109A5042251160 @default.
• W2893022109 hasAuthorship W2893022109A5055279687 @default.
• W2893022109 hasAuthorship W2893022109A5056060130 @default.
• W2893022109 hasAuthorship W2893022109A5072490624 @default.
• W2893022109 hasBestOaLocation W28930221091 @default.
• W2893022109 hasConcept C126322002 @default.
• W2893022109 hasConcept C141071460 @default.
• W2893022109 hasConcept C168563851 @default.
• W2893022109 hasConcept C177713679 @default.
• W2893022109 hasConcept C194828623 @default.
• W2893022109 hasConcept C2777284639 @default.
• W2893022109 hasConcept C2777628635 @default.
• W2893022109 hasConcept C2778165595 @default.
• W2893022109 hasConcept C2778384902 @default.
• W2893022109 hasConcept C2781300812 @default.
• W2893022109 hasConcept C42219234 @default.
• W2893022109 hasConcept C71924100 @default.
• W2893022109 hasConceptScore W2893022109C126322002 @default.
• W2893022109 hasConceptScore W2893022109C141071460 @default.
• W2893022109 hasConceptScore W2893022109C168563851 @default.
• W2893022109 hasConceptScore W2893022109C177713679 @default.
• W2893022109 hasConceptScore W2893022109C194828623 @default.
• W2893022109 hasConceptScore W2893022109C2777284639 @default.
• W2893022109 hasConceptScore W2893022109C2777628635 @default.
• W2893022109 hasConceptScore W2893022109C2778165595 @default.
• W2893022109 hasConceptScore W2893022109C2778384902 @default.
• W2893022109 hasConceptScore W2893022109C2781300812 @default.
• W2893022109 hasConceptScore W2893022109C42219234 @default.
• W2893022109 hasConceptScore W2893022109C71924100 @default.
• W2893022109 hasIssue "1" @default.
• W2893022109 hasLocation W28930221091 @default.
• W2893022109 hasLocation W28930221092 @default.
• W2893022109 hasLocation W28930221093 @default.
• W2893022109 hasLocation W28930221094 @default.
• W2893022109 hasOpenAccess W2893022109 @default.
• W2893022109 hasPrimaryLocation W28930221091 @default.
• W2893022109 hasRelatedWork W1974635083 @default.
• W2893022109 hasRelatedWork W2022768974 @default.
• W2893022109 hasRelatedWork W2026405728 @default.
• W2893022109 hasRelatedWork W2033978937 @default.
• W2893022109 hasRelatedWork W2592904605 @default.
• W2893022109 hasRelatedWork W2610490428 @default.
• W2893022109 hasRelatedWork W2994793273 @default.
• W2893022109 hasRelatedWork W4213252971 @default.
• W2893022109 hasRelatedWork W4381571381 @default.
• W2893022109 hasRelatedWork W2338096829 @default.
• W2893022109 hasVolume "3" @default.

• next